Cagle Paul J, Reams Megan, Agel Julie, Bohn Deb
Department of Orthopaedic Surgery, University of Minnesota, Minneapolis; and TRIA Orthopaedic Center, Bloomington, MN.
Department of Orthopaedic Surgery, University of Minnesota, Minneapolis; and TRIA Orthopaedic Center, Bloomington, MN.
J Hand Surg Am. 2014 Nov;39(11):2175-80. doi: 10.1016/j.jhsa.2014.07.017. Epub 2014 Sep 11.
To prospectively report the outcomes of open carpal tunnel release with respect to patient age and medical comorbidities.
Nine hundred fifty open carpal tunnel procedures in 826 patients (age range, 21-100 y) at a high-volume orthopedic surgery center were evaluated. Self-reported symptom severity and functional scores were collected using the validated Boston Carpal Tunnel Outcomes questionnaire preoperatively, and at 2 weeks, 6 weeks, and 12 weeks postoperatively.
Patients demonstrated a significant improvement in symptom severity scores at 2 weeks and functional severity scores at 6 weeks. Documented patient medical comorbidities did not affect improvement after surgery. Patients with diabetes improved more slowly but were not significantly different at 6 weeks. Patients with workers' compensation insurance were significantly worse at baseline, 2 weeks, and 6 weeks but were not significantly different at 3 months. The risk of negative postoperative endpoints was slightly higher in patients with a medical comorbidity, though not statistically different.
Significant improvements in symptom severity and hand function may be expected after open carpal tunnel release in the general population regardless of age, medical comorbidities, or workers' compensation status.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic III.
前瞻性报告开放性腕管松解术在患者年龄和合并症方面的治疗结果。
对一家大型骨科手术中心826例患者(年龄范围21 - 100岁)进行的950例开放性腕管手术进行了评估。术前以及术后2周、6周和12周,使用经过验证的波士顿腕管综合征疗效问卷收集患者自我报告的症状严重程度和功能评分。
患者在术后2周时症状严重程度评分有显著改善,在术后6周时功能严重程度评分有显著改善。记录在案的患者合并症并不影响术后的改善情况。糖尿病患者改善较慢,但在6周时差异无统计学意义。有工伤赔偿保险的患者在基线、2周和6周时情况明显更差,但在3个月时差异无统计学意义。合并症患者术后出现不良结局的风险略高,但无统计学差异。
无论年龄、合并症或工伤赔偿状况如何,一般人群开放性腕管松解术后症状严重程度和手部功能有望得到显著改善。
研究类型/证据水平:治疗性III级。